Skip to content

Perturbation-Based Treadmill Training to Prevent Unrecovered Falls in Geriatric Patients

Training at the Limit of Balance Control on a Perturbation Treadmill to Prevent Unrecovered Falls in Geriatric Patients With and Without Cognitive Impairment

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06652828
Acronym
TRAIL
Enrollment
396
Registered
2024-10-22
Start date
2024-11-25
Completion date
2027-04-30
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Exercise, Fall Prevention, Geriatrics, Perturbation

Keywords

treadmill, unrecovered falls, fall risk, training, falls, balance, rehabilitaion

Brief summary

The goal of this clinical trial is to determine the effectiveness of perturbation-based balance training (PBT) in preventing unrecovered falls among geriatric patients aged ≥70 years with a prospective fall risk of ≥40%. The study will also assess the safety and feasibility of PBT. The main research questions are: A total of 396 participants will receive 9 training sessions of either PBT or conventional treadmill training and will attend an assessment before and after the intervention, as well as 6 and 12 months follow up. Falls will be documented throughout the entire study period using calendars, telephone interviews, and proxy information. The primary outcome, unrecovered falls, will be recorded after the end of the intervention until 12 months follow up.

Detailed description

Falls are common and the leading cause of injuries among older adults, but falls may be attenuated by the promising and time-efficient intervention called perturbation-based balance training (PBT). The aim of the TRAIL-study is to confirm the effectiveness of a treadmill PBT protocol for preventing unrecovered falls in geriatric patients with and without cognitive impairment. This study is designed as a confirmatory, multicenter, assessor-blinded, randomized controlled study. The 396 geriatric patients aged ≥70 years with ≥40% prospective fall risk and being capable of walking ≥70 m in a 2-Minute Walk Test will receive 9 sessions of PBT on a treadmill (intervention) or a conventional treadmill training (control group; CTT). Outcome assessments will be performed shortly after the intervention interval as well as 6 and 12 months thereafter. The primary outcome is defined as unrecovered falls (defined as falls in which persons who fell are unable to get up independently) within 12-month follow-up. Falls are documented over at least 12 months using calendars, telephone interviews, and proxy information. Secondary outcomes include mobility, balance performance, concerns about falling, physical activity and capacity, stepping responses, health-related quality of life, cognitive functioning, mobility, reactive dynamic balance and training acceptability of PBT. The study will be accompanied by a patient advisory board and an expert advisory board and focus groups will be conducted to involve the target group. Based on pilot studies and the available literature, we expect a ≥50% reduction of unrecovered falls during the following year in the intervention group (PBT) compared to the control group (CTT).

Interventions

OTHERConventional Treadmill Walking (CTT)

The CTT serves as a comparison to PBT. It involves standard treadmill walking without perturbations on the same treadmill. This intervention is conducted over the same defined period as PBT (3-6 weeks), with a matched frequency and exercise time compared to the PBT group for consistency. Participants are secured with safety harnesses while walking.

Overall, 9 training sessions with different objectives and progression regarding perturbation directions, predictability, and intensity will be conducted within 3-6 weeks. During the initial sessions, familiarizing participants with the treadmill and establishing their individual walking pace will be focused. Pace can be individually adjusted in each training session. Participants are secured with safety harnesses while walking.

Sponsors

Marienhospital Herne
CollaboratorOTHER
University of Ulm
CollaboratorOTHER
University of Konstanz
CollaboratorOTHER
University Hospital RWTH Aachen University, Aachen, Germany.
CollaboratorUNKNOWN
Robert Bosch-Krankenhaus Stuttgart
CollaboratorUNKNOWN
Heidelberg University Hospital, Heidelberg, Germany
CollaboratorUNKNOWN
Technische Hochschule Ulm
CollaboratorUNKNOWN
University of Oldenburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 70 years * ≥40% prospective fall risk for the following year according to the Fall Risk Assessment Tool (FRAT-up) * Walking distance ≥ 70 m in the 2 Minute Walk Test * Possibility to reach the study site at least via taxi * Written informed consent, obtained according to international guidelines and local laws

Exclusion criteria

* MoCA score \< 10 pts (or MMSE \< 17 pts) * Performing a Timed up and Go test (TUG) \<10 s * Leg amputation * Osteosynthesis or joint replacement of lower extremities within the past 6 weeks. * Blindness * Parkinson's disease with Hoehn and Yahr stage \> 3 * Body weight \>135 kg and height \>185 cm * Life-expectancy \<12 months, instable or severe illness * Inability to communicate verbally and coorporate appropriatly * (Prior) participation perturbation training programs * Gait-relevant foot-drop paresis

Design outcomes

Primary

MeasureTime frameDescription
Rate of unrecovered fallsContinuously from intervention end until 12 months after the end of the interventionFalls are assessed using fall calendars, telephone interviews, and proxy information.

Secondary

MeasureTime frameDescription
Rate of fallsContinuously from intervention end until 12 months after the end of the interventionFalls are assessed using fall calenders, telephone interviews, and proxy information.
Physical activityBefore the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionPhysical activity will be measured over 7 days using a body-fixed inertial measurement unit (AX6, Axivity Ltd., Newcastle, UK) , which will be placed at lumbar level (L5) of the participant. The sensor measures linear acceleration data in 3 dimensions in combination with angular data. From these data, besides others, time spent with physical activity, steps as well as time spent in the supine sitting or standing position can be determined and reported. Data will be used to describe the participants and to report falls per physical activity.
Stepping response (a)12 months after the interventionModified Stepping Threshold Tests (i.e. single step, multiple step threshold). Participants will experience suface perturbations in ante-posterior as well as mediolateral direction with increasing intensity until they have to perform a single compensatory step or multiple steps to recover balance. Higher perturbation levels for the single or multiple step threshold indicate better static reactive balance.
Stepping reponse (b)Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionChoice Stepping Reaction Test
Cognitive functioning (a)Before the training intervention (up to 4 weeks before the beginning of the training), and 12 months after the interventionMontreal Cognitive Assessment (MoCA). Minimum value: 0 points; Maximum value: 30 points; higher values indicate better cognitive functioning.
Cognitive functioning (b)Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionTMT (Trail Making Test)
Concerns about fallingBefore the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionShort Falls Efficacy Scale International (Short FES-I). Minimum value: 7 points, Maximum value: 28 points; higher values indicate more concerns about falling.
Health-related quality of lifeBefore the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionEuro Quality of Life with visual analogue scales (EQ-VAS), values of 0-100: lower values indicate worse subjective health; EuroQol 5-Dimensions 5-Levels
Physical capacity (b)Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionSPPB (Short Physical Performance Battery), including balance, leg strength and gait speed; minimum value: 0 points; maximum value: 12 points; higher values indicate better physical capacity.
Physical capacity (c)Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionTUG (Timed Up and Go-Test)
Nutritional statusBefore the training intervention (up to 4 weeks before the beginning of the training), 6 months after the intervention, and 12 months after the interventionMNA (Mini Nutritional Assessment); values of 0-30: lower values indicate worse nutritional status
Reactive dynamic balance (a)3rd (during the on average 1st week of the intervention) and last training session (during the on average 3rd week, at maximum 6th week of the intervention) (intervention group only), and 12 months after the intervention (intervention and control group)Adapted Compensatory Arm and Leg Movements after perturbations induced on the treadmill during walking. Minimum value: 16 points; Maximum value: 108 points; higher values indicate better reactive dynamic balance.
Reactive dynamic balance (b)3rd (during the on average 1st week of the intervention) and last training session (during the on average 3rd week, at maximum 6th week of the intervention) (intervention group only), and 12 months after the intervention (intervention and control group)Spatio-temporal, kinematic and stability parameters (video-based, inertial measurement units and center of pressure data)
Laboratory fallsduring 3rd (on average 1st week of the intervention) and last training session (on average 3rd week, at maximum 6th week of the intervention; intervention group only), and 12 months after the intervention (intervention and control group)Falls after perturbations on the treadmill. A fall is determined based on video recordings. A fall is defined as unambiguous support by the safety harness after the perturbation.
Acceptability of PBTduring the last training session (during the on average 3rd week, at maximum 6th week of the intervention, in the intervention group only)Theoretical Framework of Acceptability-based Questionnaire
Vibration sensationBefore the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the interventionVibration measurement at the inner ankle using a tuning fork. Minimum value: 1 point, Maximum value: 8 points; higher values indicate higher sensation
Physical capacity (a)Before the training intervention (up to 4 weeks before the beginning of the training), after the intervention (up to 8 weeks after its beginning), 6 months after the intervention, and 12 months after the intervention2MWT (2 Minute Walk Test )

Other

MeasureTime frameDescription
Assessment of safetyContinuously from baseline assessment until 12 months after the end of the intervention (intervention starts at maximum 4 weeks after baseline assessment)Intervention-related adverse events

Countries

Germany

Contacts

Primary ContactTania Prof. Dr. med. Zieschang
tania.zieschang@uol.de+49 441 798-4760
Backup ContactJessica PD Dr. Koschate-Storm
jessica.koschate-storm@uol.de+49 441 798-4760

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026